Apple, which slumped 3% to $106.84 a share, has lost 22.6% from its intraday record high of $137.98 on September 2
Pharma & Biotech
Pharma & Biotech
Namaste Technologies debuts new marketplace platform VendorLink for cannabis accessories
CEO Tyler Robson said Valens made the “widest range and highest number of oil-based products”...
Adjupharm, the German subsidiary of IM Cannabis Corp, will provide EU Good Manufacturing...
Boldt Runners' Cannadips CBD is the leading CBD oral pouch brand in America, and Lexaria's...
The cannabinoid medicine is supported by clinical trial data in patients with chronic insomnia...
Pharma & Biotech
Luminex Resources Corp. (TSXV: LR) (OTCQX: LUMIF) CEO Marshall Koval tells Proactive the Vancouver-based mining company is making progress on its Condor Gold-Copper Project in Zamora-Chinchipe Province, southeast Ecuador. Koval says the group has advanced metallurgy at the site, continuing to...
Director Interviews
KORE Mining Ltd reveals PEA that shows 'strong economic returns'...
Director Interviews
Energy Fuels says US gov't is taking 'a step in the right...
Director Interviews
Esports Entertainment sees 4x registered users, customer deposits...
Director Interviews
BioPorto Diagnostics reveals progress on its co-developed...
Tesla’s 'battery day' next Tuesday could be ground-breaking for several industries
There is speculation that among the electric car-marker's announcments may be a cobalt-free...
The New Jersey-based company's lead product candidate, MAT9001 is for the treatment of...
The gold price hit new all-time highs in mid-August
The group already enjoys one of the largest NI 43-101 uranium resources compared to peers and...
All eyes are on Zynerba's meeting with the FDA in the fourth quarter of 2020 to discuss pivotal...
Hardware & electrical equipment
Cannabis
Gold & silver
Pharma & Biotech
Pharma & Biotech
Big caps
Small caps
Director Interviews
Director Interviews
Get our market previews and stories before the main networks.
Not just the FTSE. Read about
opportunities from the whole
equities market.
Hear directors at first-hand
or meet them in person at our events.
Watch IPOs and access on the same terms as the institutions.
